2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
3
Recruiting
2
Not yet recruiting
2
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Dermatologic
1
Conditions
Ovarian Neoplasms
1
Nevi and Melanomas
1
Melanoma
1
Interventions
pembrolizumab
562
Specimen Handling
490
Carboplatin
451
Magnetic Resonance Spectroscopy
444
Cyclophosphamide
418
Cisplatin
406
Radiotherapy
353
Gemcitabine
314
Bevacizumab
313
Paclitaxel
298
Biopsy
290
Drug Therapy
283
Blood Specimen Collection
248
Capecitabine
245
Oxaliplatin
241
fludarabine
240
Nivolumab
234
venetoclax
221
Injections
213
Docetaxel
211
Fluorouracil
205
Dexamethasone
187
Radiosurgery
182
Rituximab
159
Standard of Care
158
Pemetrexed
156
Surgical Procedures, Operative
148
durvalumab
145
atezolizumab
145
Leucovorin
139
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Sequence Analysis, RNA
×
Clear all
NCT06605417
2025-02-27
NevustoMel
Fundacion Clinic per a la Recerca Biomédica
Recruiting
100 enrolled
NCT04846933
2025-01-16
DECIDER
Turku University Hospital
Phase NA
Recruiting
200 enrolled